F2, coagulation factor II, thrombin, 2147

N. diseases: 490; N. variants: 42
Disease: Lymphoproliferative Disorder of the Skin ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1333177
Disease: Lymphoproliferative Disorder of the Skin
Lymphoproliferative Disorder of the Skin 		0.020 Biomarker disease BEFREE Prothrombin time (PT) and international normalized ratio (INR) are unreliable measures of bleeding risk and hemostasis in CLD. 31343417 2019
CUI: C1333177
Disease: Lymphoproliferative Disorder of the Skin
Lymphoproliferative Disorder of the Skin 		0.020 GeneticVariation disease BEFREE This study aimed to establish a new model for predicting acute-on-chronic liver failure (ACLF) (defined by the Chinese Medical Association), which potentially occurs among patients with acute deterioration (AD) of hepatitis B virus (HBV)-related chronic liver disease (CLD).A total of 754 patients with AD of HBV-related CLD (total bilirubin (TBIL) > 51.3 μmol/L and prothrombin activity (PTA) < 60%, 40% < PTA < 60% when TBIL ≥ 171.1 μmol/L) were retrospectively analyzed and divided into a training cohort (580 patients) and a validation cohort (174 patients). 30142800 2018